Evidence map›Paper›PMID 41262259›Full record

SynthesisFrontiers in endocrinology2025

Variation spectra in mild isolated hyperthyrotropinemia: pilot cohort and systematic review.

Valentina Ricci, María E Masnata, María D Villanueva Gonzalez, Rosa E Enacán, Agustín Izquierdo, Ezequiela Adrover, María Esnaola Azcoiti, Gabriela Sansó, Paula A Scaglia, Carina M Rivolta and 6 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Valentina RicciCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
María E MasnataCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
María D Villanueva GonzalezCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Rosa E EnacánCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Agustín IzquierdoCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Ezequiela AdroverCátedra de Genética. Departamento de Microbiología, Inmunología, Biotecnología y Genética. Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina.
María Esnaola AzcoitiCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Gabriela SansóCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Paula A ScagliaCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Carina M RivoltaCátedra de Genética. Departamento de Microbiología, Inmunología, Biotecnología y Genética. Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina.
Héctor M TargovnikCátedra de Genética. Departamento de Microbiología, Inmunología, Biotecnología y Genética. Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina.
Rodolfo A ReyCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
María G RopelatoCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Ana E ChiesaCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.
Juan P NicolaDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Mariana L TellecheaCentro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET - FEI - División de Endocrinología, Hospital de Niños Ricardo Gutiérrez (HNRG), Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lower thyrotropin (TSH) cutoffs for Congenital Hypothyroidism (CH) during the neonatal period and childhood have led to increased detection of Mild Isolated Hyperthyrotropinemia (MIH) or Subclinical Hypothyroidism; however, genetic testing has been limited in this setting. We aimed to evaluate the contribution and molecular spectrum of genetic variants in MIH. Methods: Ten patients underwent targeted Next-Generation Sequencing (NGS). Data was analyzed for Single Nucleotide Variants (SNVs), short insertions/deletions, noncanonical splice site (NCSS) variants, and Copy Number Variants (CNVs) in 13 candidate genes associated with thyroid dyshormonogenesis and isolated thyroid hypoplasia. To provide an expanded view of the genes and variants associated with MIH, we performed a Systematic Review (SR) and variant reclassification. Results: Eight monoallelic SNVs affecting 4 genes were identified in 5 subjects. A potential digenic or pseudo-digenic inheritance was identified in 3 infants. One novel variant was found in the Conclusion: Results provide further evidence for the elucidation of the genetic etiology of MIH and expand the phenotypic and variant spectrum of CH. Future, more extensive prospective studies are needed to investigate the utility of NGS in guiding treatment decisions and predicting prognosis for MIH patients.

Indexed as

Congenital HypothyroidismPolymorphism, Single NucleotideThyrotropinChild, PreschoolCohort StudiesDNA Copy Number VariationsFemaleHigh-Throughput Nucleotide SequencingHumansInfantInfant, NewbornMalePilot ProjectsThyrotropincongenital hypothyroidismgenetic diagnosishyperthyrotropinemianext generation sequencingsingle nucleotide variantssubclinical hypothyroidismsystematic revisionthyroid dyshormonogenesis

Identifiers

PMID41262259
PMCPMC12623176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.